Datavant, a data sharing technology startup for providers and life science companies, last week closed $40 million in Series B funding. Transformation Capital headlined the raise, which saw contributions from new backers Johnson & Johnson Innovation – JJDC and Cigna Ventures in addition to those of prior investors Roivant Sciences and Flex Capital. Read the […]

Datavant, a health IT company, received $40 million in Series B funding. Transformation Capital led the round with participation by new investors Johnson & Johnson Innovation – JJDC, Inc. and Cigna Ventures. Existing shareholders also took part, including Roivant Sciences and Flex Capital. Datavant’s technology enables a match between a consenting patient’s study data and […]

“At Cigna Ventures, we are committed to investing in bold, new ways to make high-quality healthcare simpler and more affordable,” Sahil Choudhry, managing director at Cigna Ventures, said in a statement. Read the full article

The company’s $50 million Series D round was co-led by Advance Venture Partners and Bessemer Venture Partners, with additional participation from Cigna Ventures and existing investors such as Jeff Weiner, executive chairman of LinkedIn, and Kaiser Permanente Ventures. To date, Ginger has raised roughly $120 million. Read the full article

AristaMD, a San Diego-based startup facilitating eConsults, raised $18 million in a series B round led by Cigna Ventures and MemorialCare Innovation Fund. The company plans to use the additional funds to expand its footprint across the U.S. Read the full article